Two Sigma Investments, LP Viking Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$40.3 Billion
Q1 2024

A detailed history of Two Sigma Investments, LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 60,846 shares of VKTX stock, worth $3.14 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

60,846

Previous 118,946 48.85%

Holding current value

$3.14 Million

Previous $2.21 Million 125.44%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.4 - $94.5 $1.01 Million - $5.49 Million	-58,100 Reduced 48.85%	60,846 $4.99 Million
Q4 2023 Feb 14, 2024	SELL	$9.24 - $19.64 $4.61 Million - $9.81 Million	-499,244 Reduced 80.76%	118,946 $2.21 Million
Q3 2023 Nov 14, 2023	BUY	$10.92 - $16.0 $2.17 Million - $3.18 Million	199,016 Added 47.48%	618,190 $6.84 Million
Q2 2023 Aug 14, 2023	SELL	$14.84 - $24.79 $4.1 Million - $6.86 Million	-276,531 Reduced 39.75%	419,174 $6.79 Million
Q1 2023 May 15, 2023	SELL	$8.08 - $17.33 $4.6 Million - $9.87 Million	-569,483 Reduced 45.01%	695,705 $11.6 Million

Q4 2022 Feb 14, 2023	BUY	$2.72 - $9.4 $758,512 - $2.62 Million	278,865 Added 28.27%	1,265,188 $11.9 Million
Q3 2022 Nov 14, 2022	SELL	$2.55 - $3.89 $141,981 - $216,591	-55,679 Reduced 5.34%	986,323 $2.68 Million
Q2 2022 Aug 15, 2022	SELL	$2.11 - $3.15 $426,409 - $636,583	-202,090 Reduced 16.24%	1,042,002 $3.01 Million
Q1 2022 May 16, 2022	BUY	$3.0 - $4.88 $931,833 - $1.52 Million	310,611 Added 33.27%	1,244,092 $3.73 Million
Q4 2021 Feb 14, 2022	BUY	$4.6 - $6.72 $262,922 - $384,095	57,157 Added 6.52%	933,481 $4.29 Million
Q3 2021 Nov 15, 2021	BUY	$5.58 - $7.04 $269,960 - $340,595	48,380 Added 5.84%	876,324 $5.5 Million
Q2 2021 Aug 16, 2021	SELL	$5.19 - $6.73 $1.53 Million - $1.98 Million	-294,887 Reduced 26.26%	827,944 $4.96 Million
Q1 2021 May 17, 2021	BUY	$5.74 - $9.67 $4.78 Million - $8.05 Million	832,611 Added 286.89%	1,122,831 $7.1 Million
Q4 2020 Feb 16, 2021	BUY	$5.3 - $6.71 $1.2 Million - $1.51 Million	225,596 Added 349.09%	290,220 $1.63 Million
Q3 2020 Nov 16, 2020	SELL	$5.73 - $8.11 $2.28 Million - $3.22 Million	-397,276 Reduced 86.01%	64,624 $376,000
Q2 2020 Aug 14, 2020	BUY	$4.35 - $8.08 $2.01 Million - $3.73 Million	461,900 New	461,900 $3.33 Million
Q1 2019 May 15, 2019	SELL	$7.58 - $9.94 $2.95 Million - $3.87 Million	-389,620 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$7.16 - $16.21 $2.79 Million - $6.32 Million	389,620 New	389,620 $2.98 Million

Others Institutions Holding VKTX

# of Institutions

426

Shares Held

63.1M

Call Options Held

7.39M

Put Options Held

5.13M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $3.95B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Viking Therapeutics, Inc. Transaction History